Mitchel Sivilotti

Mitchel Sivilotti has a diverse background in the biotechnology industry, with experience in various leadership roles at companies such as CCRM, Cesca Therapeutics, and TotipotentRX. Mitchel is currently the Chief Executive Officer of OmniaBio and serves as a Board Member at Standards Coordinating Body (SCB). With a Master's in Finance from Queen's University and degrees in Biology, Cellular and Molecular Biology, Mitchel has a strong educational foundation to support their successful career in the field.